• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镓卟啉类似物ATX-70对人白血病细胞的声动力毒性

Sonodynamic toxicity of gallium-porphyrin analogue ATX-70 in human leukemia cells.

作者信息

Miyoshi N, Misík V, Riesz P

机构信息

Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Radiat Res. 1997 Jul;148(1):43-7.

PMID:9216617
Abstract

Low concentrations (> or = 1 microM) of the gallium-porphyrin analogue ATX-70 significantly enhanced cellular toxicity in human leukemia HL-525 cells exposed to 50 kHz ultrasound. The mechanism of this ATX-70-dependent sonosensitization is unknown, but we have established the requirement of extracellular localization of ATX-70 molecules for sonosensitization. Short-lived toxic intermediates produced from ATX-70 by ultrasound are implicated in the mechanism, since no cytotoxicity was found when medium containing ATX-70 was sonicated and subsequently added to the cells. However, we were unable to demonstrate the existence of radical intermediates by EPR spin trapping with the nitroso spin trap, DBNBS, and ATX-70-dependent sonotoxicity could not be ameliorated by the addition of up to 70 mM POBN and DMPO spin traps during ultrasound exposure.

摘要

低浓度(≥1微摩尔)的镓卟啉类似物ATX - 70能显著增强暴露于50千赫超声波下的人白血病HL - 525细胞的细胞毒性。这种依赖于ATX - 70的声敏化机制尚不清楚,但我们已经确定ATX - 70分子的细胞外定位是声敏化所必需的。超声作用于ATX - 70产生的短寿命毒性中间体与该机制有关,因为当含有ATX - 70的培养基被超声处理后再添加到细胞中时未发现细胞毒性。然而,我们无法通过用亚硝基自旋捕获剂DBNBS进行电子顺磁共振自旋捕获来证明自由基中间体的存在,并且在超声暴露期间添加高达70毫摩尔的POBN和DMPO自旋捕获剂并不能改善ATX - 70依赖的声毒性。

相似文献

1
Sonodynamic toxicity of gallium-porphyrin analogue ATX-70 in human leukemia cells.镓卟啉类似物ATX-70对人白血病细胞的声动力毒性
Radiat Res. 1997 Jul;148(1):43-7.
2
Correlation between sonochemistry of surfactant solutions and human leukemia cell killing by ultrasound and porphyrins.
Free Radic Biol Med. 2003 Mar 15;34(6):710-9. doi: 10.1016/s0891-5849(02)01428-4.
3
Effect of gallium-porphyrin analogue ATX-70 on nitroxide formation from a cyclic secondary amine by ultrasound: on the mechanism of sonodynamic activation.镓卟啉类似物ATX - 70对超声作用下环状仲胺形成氮氧化物的影响:关于声动力激活机制
Radiat Res. 1995 Aug;143(2):194-202.
4
Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen.使用与癌胚抗原抗体偶联的光敏剂对癌症进行靶向声动力治疗。
Anticancer Res. 2002 May-Jun;22(3):1575-80.
5
Sonodynamically induced apoptosis and active oxygen generation by gallium-porphyrin complex, ATX-70.超声辐照血卟啉衍生物(Ga-porphyrin)ATX-70 诱导的凋亡及活性氧产生
Cancer Chemother Pharmacol. 2010 Nov;66(6):1071-8. doi: 10.1007/s00280-010-1264-6. Epub 2010 Mar 5.
6
Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70.化学诱导乳腺肿瘤的声动力治疗:镓卟啉复合物ATX-70的药代动力学、组织分布及声动力诱导的抗肿瘤作用
Cancer Chemother Pharmacol. 2007 Nov;60(6):891-7. doi: 10.1007/s00280-007-0436-5. Epub 2007 Apr 11.
7
Application of high energy shock waves to cancer treatment in combination with cisplatin and ATX-70.高能冲击波联合顺铂和ATX-70在癌症治疗中的应用。
Anticancer Res. 1999 May-Jun;19(3A):1989-93.
8
Peroxyl radical formation in aqueous solutions of N,N-dimethylformamide, N-methylformamide, and dimethylsulfoxide by ultrasound: implications for sonosensitized cell killing.超声作用下N,N-二甲基甲酰胺、N-甲基甲酰胺和二甲基亚砜水溶液中过氧自由基的形成:对声敏化细胞杀伤的影响
Free Radic Biol Med. 1996;20(1):129-38. doi: 10.1016/0891-5849(95)02009-8.
9
Sonodynamic treatment of murine tumor through second-harmonic superimposition.
Ultrasound Med Biol. 2004 Sep;30(9):1233-8. doi: 10.1016/j.ultrasmedbio.2004.07.008.
10
Sonodynamic therapy of cancer using novel sonosensitizers.使用新型声敏剂的癌症声动力疗法。
Anticancer Res. 2007 Nov-Dec;27(6A):3673-7.

引用本文的文献

1
Nanotechnology-enabled sonodynamic therapy against malignant tumors.基于纳米技术的恶性肿瘤声动力治疗
Nanoscale Adv. 2024 Mar 26;6(8):1974-1991. doi: 10.1039/d3na00738c. eCollection 2024 Apr 16.
2
ROS regulation in gliomas: implications for treatment strategies.ROS 调控在神经胶质瘤中的作用:对治疗策略的启示。
Front Immunol. 2023 Dec 7;14:1259797. doi: 10.3389/fimmu.2023.1259797. eCollection 2023.
3
Evolution of gallium applications in medicine and microbiology: a timeline.镓在医学和微生物学中的应用的演变:一个时间轴。
Biometals. 2022 Aug;35(4):675-688. doi: 10.1007/s10534-022-00406-4. Epub 2022 Jun 21.
4
Therapeutic potential of low-intensity ultrasound (part 2): biomolecular effects, sonotransfection, and sonopermeabilization.低强度超声的治疗潜力(第2部分):生物分子效应、超声转染和超声透化作用
J Med Ultrason (2001). 2008 Dec;35(4):161-7. doi: 10.1007/s10396-008-0195-x. Epub 2008 Dec 16.
5
Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy.声波与抗肿瘤药物:强化联合抗癌疗法的可能性
J Med Ultrason (2001). 2002 Dec;29(4):173-87. doi: 10.1007/BF02480848.
6
Combination of Sonodynamic and Photodynamic Therapy against Cancer Would Be Effective through Using a Regulated Size of Nanoparticles.通过使用尺寸可控的纳米颗粒,声动力与光动力联合治疗癌症将行之有效。
Nanosci Nanoeng. 2016 Feb;4(1):1-11. doi: 10.13189/nn.2016.040101.
7
In vitro study of low intensity ultrasound combined with different doses of PDT: Effects on C6 glioma cells.低强度超声联合不同剂量光动力疗法对C6胶质瘤细胞影响的体外研究
Oncol Lett. 2013 Feb;5(2):702-706. doi: 10.3892/ol.2012.1060. Epub 2012 Dec 4.
8
In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells.血卟啉单甲醚介导的声动力效应在体外对C6胶质瘤细胞作用的研究
Neurol Sci. 2008 Sep;29(4):229-35. doi: 10.1007/s10072-008-0972-8. Epub 2008 Sep 20.
9
Quinone-enhanced sonochemical production of nitric oxide from s-nitrosoglutathione.醌增强声化学法从S-亚硝基谷胱甘肽生成一氧化氮
Ultrason Sonochem. 2009 Jan;16(1):190-6. doi: 10.1016/j.ultsonch.2008.05.009. Epub 2008 May 24.
10
Enhanced antitumor activity of ultrasonic irradiation in the presence of new quinolone antibiotics in vitro.新型喹诺酮类抗生素存在下超声辐照在体外增强的抗肿瘤活性。
Cancer Sci. 2004 Oct;95(10):845-9. doi: 10.1111/j.1349-7006.2004.tb02192.x.